4.6 Review

Proton Therapy for Squamous Cell Carcinoma of the Head and Neck: Early Clinical Experience and Current Challenges

Related references

Note: Only part of the references are listed.
Article Otorhinolaryngology

An comparison of acute toxicities and patient-reported outcomes between intensity-modulated proton therapy and volumetric-modulated arc therapy after ipsilateral radiation for head and neck cancers

Elizabeth B. Jeans et al.

Summary: IMPT is associated with decreased dose to OARs and less patient-reported acute deterioration in multiple head and neck domains. Physician-reported toxicities demonstrated less oral pain. Strong consideration for IMPT in ipsilateral head and neck patients with cancer is warranted.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2022)

Article Oncology

Current practice in proton therapy delivery in adult cancer patients across Europe

Makbule Tambas et al.

Summary: This study investigated the current practice of proton therapy in European adult cancer patients. The results showed that central nervous system tumors and head and neck cancer were the most frequently treated tumor types, and most centers used indication protocols for treatment. Lack of evidence and reimbursement issues were the main reasons for not treating certain tumor types.

RADIOTHERAPY AND ONCOLOGY (2022)

Article Oncology

A Decision Support Tool to Optimize Selection of Head and Neck Cancer Patients for Proton Therapy

Makbule Tambas et al.

Summary: A decision support tool has been developed to select head and neck cancer patients for proton therapy. The tool predicts the reduction in expected toxicity risk with proton therapy using delineation data and can be used before treatment planning. The tool has a positive predictive value of over 90%, reducing treatment delays significantly.

CANCERS (2022)

Article Oncology

Evaluation of robustly optimised intensity modulated proton therapy for nasopharyngeal carcinoma

Daniel Scandurra et al.

Summary: This study evaluated the dosimetric changes during the treatment course for nasopharyngeal carcinoma (NPC) patients treated with robustly optimised intensity modulated proton therapy (IMPT). The results showed that the IMPT plans provided robust target coverage and acceptable organ-at-risk dose variation in NPC patients when accumulated over longitudinal data.

RADIOTHERAPY AND ONCOLOGY (2022)

Article Otorhinolaryngology

Proton pencil-beam scanning radiotherapy in the treatment of nasopharyngeal cancer: dosimetric parameters and 2-year results

Jiri Kubes et al.

Summary: Patients with nasopharyngeal cancer treated with proton pencil-beam scanning radiotherapy showed promising treatment outcomes and mild acute toxicity. The study highlighted the feasibility of proton therapy in this group of patients with advanced disease.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

Model based patient pre-selection for intensity-modulated proton therapy (IMPT) using automated treatment planning and machine learning

Jasper Kouwenberg et al.

Summary: The study used machine learning and automated treatment planning for pre-selection of head and neck cancer patients, showing a significant reduction in unnecessary manual IMPT planning. Pre-selection with the classifier can reduce the occurrence of negative outcomes, saving costs, labor, and time.

RADIOTHERAPY AND ONCOLOGY (2021)

Review Otorhinolaryngology

Unilateral versus bilateral nodal irradiation: Current evidence in the treatment of squamous cell carcinoma of the head and neck

Sandra Nuyts et al.

Summary: Improvements in diagnostic imaging techniques have led to a reevaluation of the current practice of bilateral elective neck irradiation for head and neck cancers. There is growing interest in more targeted and selective nodal irradiation approaches to reduce treatment-related toxicity, particularly in patients with small metastases that were previously included in elective nodal volumes.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2021)

Article Oncology

Comprehensive toxicity risk profiling in radiation therapy for head and neck cancer: A new concept for individually optimised treatment

Lisa Van den Bosch et al.

Summary: The study developed and externally validated NTCP models for various toxicities in head and neck cancer patients, involving 14 organs associated with at least one toxicity. The oral cavity was the predominant organ, while important organs included the parotid and submandibular glands, buccal mucosa, and swallowing muscles. The models showed a median discrimination performance of 0.71 at internal validation and 0.67 at external validation.

RADIOTHERAPY AND ONCOLOGY (2021)

Review Medicine, General & Internal

Head and neck cancer

Mayur D. Mody et al.

Summary: Head and neck cancer is the seventh most common type of cancer worldwide, with the predominant risk factors being tobacco use, alcohol abuse, and oncogenic viruses. Treatment typically involves a multidisciplinary approach with surgery, radiotherapy, and systemic therapy, and is challenging due to site-specific and histology-specific variations.

LANCET (2021)

Article Oncology

Anatomic changes in head and neck intensity-modulated proton therapy: Comparison between robust optimization and online adaptation

Arthur Lalonde et al.

Summary: This study compared the impact of setup variations and anatomical changes on the quality of head and neck IMPT treatments. The results showed that daily online-adapted plans can achieve superior target coverage and lower dose to organs at risk compared to robust optimization methods.

RADIOTHERAPY AND ONCOLOGY (2021)

Article Oncology

Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia

Jianzhong Cao et al.

Summary: The study showed that in patients with oropharyngeal cancer, IMPT treatment was associated with less late xerostomia compared to IMRT treatment. Dosimetric variables related to the oral cavity were associated with late xerostomia.

RADIOTHERAPY AND ONCOLOGY (2021)

Article Oncology

Intensity Modulated Proton Beam Therapy versus Volumetric Modulated Arc Therapy for Patients with Nasopharyngeal Cancer: A Propensity Score-Matched Study

Yung-Chih Chou et al.

Summary: IMPT may provide better oncologic outcomes compared to VMAT in patients with nasopharyngeal carcinoma, with reduced rates of NG tube insertion and body weight loss, but it also increases the risk of grade III radiation dermatitis.

CANCERS (2021)

Article Medicine, General & Internal

Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy

Xingzhe Li et al.

Summary: This study compared the toxic effects and oncologic outcomes of patients with nonmetastatic NPC treated with IMPT vs IMRT with or without chemotherapy. The results showed that IMPT was associated with lower acute toxicity burden compared with IMRT, rare late complications, and excellent oncologic outcomes, including 100% locoregional control at 2 years.

JAMA NETWORK OPEN (2021)

Article Oncology

Intensity-Modulated Proton Therapy for Nasopharynx Cancer: 2-year Outcomes from a Single Institution

Vonetta M. Williams et al.

Summary: Advances in radiotherapy have improved tumor control and reduced toxicity in the management of nasopharyngeal carcinoma. Proton therapy with intensity-modulated proton therapy (IMPT) has shown potential in improving therapeutic ratio for NPC. The 2-year clinical outcomes with IMPT for NPC demonstrated excellent local regional control and favorable toxicity profile, supporting its clinical use.

INTERNATIONAL JOURNAL OF PARTICLE THERAPY (2021)

Article Oncology

National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer

Johannes A. Langendijk et al.

Summary: In the Netherlands, a model-based approach is used to identify head and neck cancer patients who may benefit most from proton therapy in preventing late radiation-induced side effects compared to photon therapy. The National Indication Protocol Proton therapy for Head and Neck Cancer patients (NIPP-HNC) has been developed, approved by health care authorities, and ensures full reimbursement for qualifying patients. This article outlines the process of developing NIPP-HNC and provides necessary information for implementing model-based selection for head and neck cancer patients in routine clinical practice.

INTERNATIONAL JOURNAL OF PARTICLE THERAPY (2021)

Review Oncology

A Systematic Review of Proton Therapy for the Management of Nasopharyngeal Cancer

Anna Lee et al.

Summary: This study systematically reviewed the literature on proton therapy in nasopharyngeal cancer patients, finding that proton therapy can maintain good treatment outcomes while reducing toxic dose to normal tissues. Compared with intensity-modulated radiation therapy, proton therapy showed lower rates of feeding tube and mucositis, indicating an improved toxicity profile in NPC patients.

INTERNATIONAL JOURNAL OF PARTICLE THERAPY (2021)

Article Oncology

Activity-Based Costing of Intensity-Modulated Proton versus Photon Therapy for Oropharyngeal Cancer

Nikhil G. Thaker et al.

Summary: In this study, time-driven activity-based costing was used to compare the costs of delivering IMPT and IMRT. The results showed that while the single-fraction costs for IMPT were higher than IMRT, the average full cycle cost of IMPT was not significantly higher than IMRT.

INTERNATIONAL JOURNAL OF PARTICLE THERAPY (2021)

Article Oncology

Cost-Effectiveness Models of Proton Therapy for Head and Neck: Evaluating Quality and Methods to Date

Danmeng Huang et al.

Summary: Only 4 formal CEMs specific to PBT for HNC have been published, with parameter inputs generally referencing older literature and applying hypothetical assumptions due to limited availability of direct clinical evidence. The study cohorts had low case numbers, some models inadequately reflected the natural history of HNC, and cost inputs were incomplete and referenced historic figures. Contemporary CEMs are needed to improve clinical applicability with respect to PBT for HNC.

INTERNATIONAL JOURNAL OF PARTICLE THERAPY (2021)

Review Radiology, Nuclear Medicine & Medical Imaging

Online daily adaptive proton therapy

Francesca Albertini et al.

BRITISH JOURNAL OF RADIOLOGY (2020)

Article Oncology

Outcomes following Proton Therapy for Squamous Cell Carcinoma of the Larynx

N. Ausat et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)

Article Oncology

Proton Therapy for Non-Skull Base Head and Neck Adenoid Cystic Carcinoma

A. Lee et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)

Article Oncology

Clinical Outcomes and Toxicities in Oropharyngeal Cancer (OPC) Patients Treated with Proton Therapy: A Single Institutional Experience

S. Kitpanit et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)

Review Oncology

Quality of Life, Toxicity and Unmet Needs in Nasopharyngeal Cancer Survivors

Lachlan McDowell et al.

FRONTIERS IN ONCOLOGY (2020)

Article Oncology

Head and Neck Cancers, Version 2.2020

David G. Pfister et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)

Article Oncology

Predicted Secondary Malignancies following Proton versus Photon Radiation for Oropharyngeal Cancers

Varsha Jain et al.

INTERNATIONAL JOURNAL OF PARTICLE THERAPY (2020)

Article Oncology

The Insurance Approval Process for Proton Radiation Therapy: A Significant Barrier to Patient Care

Matthew S. Ning et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)

Article Oncology

Insurance Approval for Proton Beam Therapy and its Impact on Delays in Treatment

Apar Gupta et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)

Article Oncology

Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus Proton Therapy for Oropharyngeal Squamous Cell Carcinoma

David J. Sher et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)

Article Oncology

Organ-Sparing in Radiotherapy for Head-and-Neck Cancer: Improving Quality of Life

Peter G. Hawkins et al.

SEMINARS IN RADIATION ONCOLOGY (2018)

Article Oncology

Clinical Trial Strategies to Compare Protons With Photons

Johannes A. Langendijk et al.

SEMINARS IN RADIATION ONCOLOGY (2018)

Article Oncology

Toward adaptive proton therapy guided with a mobile helical CT scanner

Baozhou Sun et al.

RADIOTHERAPY AND ONCOLOGY (2018)

Article Astronomy & Astrophysics

Proton radiation-induced cancer progression

Krishna Luitel et al.

LIFE SCIENCES IN SPACE RESEARCH (2018)

Article Oncology

Quality of Life of Postoperative Photon versus Proton Radiation Therapy for Oropharynx Cancer

Sonam Sharma et al.

INTERNATIONAL JOURNAL OF PARTICLE THERAPY (2018)

Article Oncology

Effect of Anatomic Changes on Pencil Beam Scanned Proton Dose Distributions for Cranial and Extracranial Tumors

Lorenzo Placidi et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

Potential proton and photon dose degradation in advanced head and neck cancer patients by intratherapy changes

Kristin Stuetzer et al.

JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

A radiobiological Markov simulation tool for aiding decision making in proton therapy referral

Annabelle M. Austin et al.

PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2017)

Article Oncology

Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer

Wencheng Zhang et al.

RADIOTHERAPY AND ONCOLOGY (2017)

Article Otorhinolaryngology

Intensity-modulated proton therapy for nasopharyngeal carcinoma: Decreased radiation dose to normal structures and encouraging clinical outcomes

Gary D. Lewis et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)

Article Oncology

Results From the Imaging and Radiation Oncology Core Houston's Anthropomorphic Phantoms Used for Proton Therapy Clinical Trial Credentialing

Paige A. Taylor et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)

Article Oncology

Reirradiation of Recurrent and Second Primary Head and Neck Cancer With Proton Therapy

Mark W. McDonald et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)

Article Oncology

Reirradiation of Head and Neck Cancers With Proton Therapy: Outcomes and Analyses

Jack Phan et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)

Article Oncology

Outcomes of Sinonasal Cancer Treated With Proton Therapy

Roi Dagan et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)

Article Oncology

Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes

Paul B. Romesser et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)

Article Oncology

Predictors of Dysgeusia in Patients With Oropharyngeal Cancer Treated With Chemotherapy and Intensity Modulated Radiation Therapy

Eli Sapir et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)

Article Oncology

Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma

G. Brandon Gunn et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)

Editorial Material Oncology

Beyond a moonshot: insurance coverage for proton therapy

Anand Shah et al.

LANCET ONCOLOGY (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Impact of interfractional changes in head and neck cancer patients on the delivered dose in intensity modulated radiotherapy with protons and photons

Birgit Sabine Mueller et al.

PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2015)

Article Oncology

Principles and Reality of Proton Therapy Treatment Allocation

Justin E. Bekelman et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)

Article Oncology

Protons in Head-and-Neck Cancer: Bridging the Gap of Evidence

Bram L. T. Ramaekers et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)

Article Oncology

Dose Uncertainties in IMPT for Oropharyngeal Cancer in the Presence of Anatomical, Range, and Setup Errors

Aafke C. Kraan et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)

Review Oncology

Second Solid Cancers After Radiation Therapy: A Systematic Review of the Epidemiologic Studies of the Radiation Dose-Response Relationship

Amy Berrington de Gonzalez et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)

Article Radiology, Nuclear Medicine & Medical Imaging

Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers

Wei Liu et al.

MEDICAL PHYSICS (2013)

Article Oncology

Health Economic Controversy and Cost-Effectiveness of Proton Therapy

Yolande Lievens et al.

SEMINARS IN RADIATION ONCOLOGY (2013)

Article Engineering, Biomedical

Range uncertainties in proton therapy and the role of Monte Carlo simulations

Harald Paganetti

PHYSICS IN MEDICINE AND BIOLOGY (2012)

Article Oncology

Using a Reduced Spot Size for Intensity-Modulated Proton Therapy Potentially Improves Salivary Gland-Sparing in Oropharyngeal Cancer

Tara A. van de Water et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)

Article Medicine, General & Internal

Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

K. Kian Ang et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Medicine, General & Internal

Rethinking pragmatic randomised controlled trials: introducing the cohort multiple randomised controlled trial design

Clare Relton et al.

BMJ-BRITISH MEDICAL JOURNAL (2010)

Article Oncology

Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: Planning comparison and NTCP evaluation

Lamberto Widesott et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)

Article Oncology

Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer

David I. Rosenthal et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)

Editorial Material Oncology

Should randomized clinical trials be required for proton radiotherapy?

Michael Goitein et al.

JOURNAL OF CLINICAL ONCOLOGY (2008)

Article Oncology

The biologic relevance of daily dose variations in adaptive treatment planning

Thomas Bortfeld et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)

Article Oncology

The relative costs of proton and X-ray radiation therapy

M Goitein et al.

CLINICAL ONCOLOGY (2003)